InfuSystem logo
InfuSystem
INFU | AMEX
Chart Builder DCF Calculator
$14.79
+$0.07 (+0.48%)
At close: Nov 16, 2026, 4:00 PM ET
$14.79
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

InfuSystem Company Profile

Company profile explained

Company Profile

InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.

Key Executives

Name Position
Carrie Lachance President, Chief Executive Officer & Director
Addam Chupa Executive Vice President & Chief Information Officer
Barry G. Steele Executive Vice President & Chief Financial Officer
Jeanie Latz Corporate Secretary
Jerod Funke Executive Vice President & Chief HR Officer

Latest SEC Filings

Date Type Title
Oct 27, 2026 8-K Current Report
Oct 13, 2026 4 Filing
Sep 17, 2026 8-K Current Report
Sep 11, 2026 4 Filing
Aug 04, 2026 10-Q Quarterly Report
Aug 04, 2026 8-K Current Report
Aug 04, 2026 8-K Current Report
Jul 28, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 28, 2026 8-K Current Report
May 19, 2026 4 Filing
View All SEC Filings ➞
InfuSystem
InfuSystem logo
Country United States
IPO Date Dec 27, 2007
Industry Medical - Devices
Sector Healthcare
Employees 467
CEO Carrie A. Lachance

Contact Details

3851 West Hamlin Road Rochester Hills, Michigan 48309 United States

Stock Details

Ticker Symbol INFU
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001337013
CUSIP Number 45685K102
ISIN Number US45685K1025
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.